Sign in
Download Opera News App



Health COVID


U. S pharmaceuticals company enters final testing phase for its coronavirus vaccine.

A coronavirus vaccine developed by a U.S company known as "Moderna" and the National Institute of Health, a medical research institution is expected to become the first in the U. S to enter the final stage of clinical testing.

Preliminary outcomes claimed it is safe and have the ability to stimulate an immune response against the coronavirus.

However, Moderna is planning to enter the 3rd phase of its clinical trial on the 27th of July this year and they are also hoping to test the vaccine on thirty thousand (30,000) individuals.

The 45 volunteers who received the vaccine as an experiment for trial in the first phase were found to be having antibodies in their blood that can fight against the coronavirus. These volunteers also had no serious side effects, and the volunteers however were youths.

Speaking to members of the press, the U.S government health advisor Anthony Fauci said there are twenty-three (23) coronavirus vaccine candidates currently around the world.

Wow!! This indeed is a good news

Content created and supplied by: Zammyclare (via Opera News )

Anthony Fauci Moderna National Institute of Health U.S


Load app to read more comments